Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Neutrophil count (procedure)
CUI: C0200633
Disease: Neutrophil count (procedure)
234 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.800 1.000 6 2011 2019
White Blood Cell Count procedure
CUI: C0023508
Disease: White Blood Cell Count procedure
1322 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.800 1.000 5 2012 2019
Monocyte count procedure
CUI: C0200637
Disease: Monocyte count procedure
296 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 2 2017 2019
Monocyte count result
CUI: C0750880
Disease: Monocyte count result
296 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 2 2017 2019
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
526 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
526 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015
Blood basophil count (lab test)
CUI: C0200641
Disease: Blood basophil count (lab test)
452 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2016 2016
Eosinophil count procedure
CUI: C0200638
Disease: Eosinophil count procedure
1144 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2016 2016
Granulocyte count
CUI: C0857490
Disease: Granulocyte count
150 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2016 2016
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
526 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
527 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015
Myeloperoxidase Measurement
CUI: C2698399
Disease: Myeloperoxidase Measurement
16 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2013 2013
DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE
CUI: C4017326
Disease: DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE
2 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 0
WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1
CUI: C2676078
Disease: WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1
1 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 0
Leukopenia
CUI: C0023530
Disease: Leukopenia
153 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.030 1.000 3 2008 2019
Neutropenia
CUI: C0027947
Disease: Neutropenia
97 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.030 1.000 3 2008 2019
Asthma
CUI: C0004096
Disease: Asthma
1536 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2008 2008
Balkan Nephropathy
CUI: C0004698
Disease: Balkan Nephropathy
4 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2018 2018
Malaria
CUI: C0024530
Disease: Malaria
148 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2019 2019
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2008 2008
Multiple Chronic Conditions
CUI: C3266262
Disease: Multiple Chronic Conditions
42 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2018 2018
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2008 2008
Triple Negative Breast Neoplasms
CUI: C3539878
Disease: Triple Negative Breast Neoplasms
99 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2019 2019
Triple-Negative Breast Carcinoma
CUI: C4722518
Disease: Triple-Negative Breast Carcinoma
96 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.010 1.000 1 2019 2019